Sculptor Capital LP Humanigen, Inc Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.33 $68,288 - $129,204	-38,800 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.66 - $8.22 $31,842 - $71,514	-8,700 Reduced 18.32%	38,800 $144,000
Q3 2021 Nov 12, 2021	BUY	$5.93 - $17.83 $210,515 - $632,964	35,500 Added 295.83%	47,500 $282,000
Q1 2021 May 14, 2021	BUY	$12.91 - $23.83 $154,920 - $285,960	12,000 New	12,000 $229,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.